VBLT - Vascular Biogenics Ltd (VBLT) CEO Dror Harats on Q2 2020 Results - Earnings Call Transcript
Vascular Biogenics Ltd (VBLT)
Q2 2020 Earnings Conference Call
August 13, 2020, 08:30 ET
Company Participants
Michael Wood - LifeSci Advisors
Dror Harats - CEO & Director
Amos Ron - CFO & Company Secretary
Conference Call Participants
Kevin DeGeeter - Oppenheimer
Jonathan Aschoff - ROTH Capital Partners
Swayampakula Ramakanth - H.C. Wainwright & Co.
Jonathan Kreizman - Valore Research
Presentation
Operator
Greetings and welcome to the VBL Therapeutics Second Quarter 2020 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Michael Wood